InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Pooler Amy. Director active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 5 disclosures have been logged. History available since 25 November 2023. The latest transaction was disclosed on 24 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Pooler Amy is a declarant linked to Sangamo Therapeutics, INC, where she is VP, HEAD OF RESEARCH. She has 5 filings in total, and across the 5 recent filings available, the most frequent transaction nature is Retenue fiscale, with amounts of EUR 2305.787036360919 on 2024-02-27, EUR 543.8257505468996 on 2024-08-27, EUR 389.5425791439899 on 2024-05-29, EUR 171.6711855265343 on 2023-11-28, and EUR 0 on 2024-01-24.